Birth Control Pills Recalled by FDA Because of Packaging Error

A popular birth control pill has been recalled by the FDA. Here's what you need to know so you aren't at risk for an unintended pregnancy.

Mibelas 24 FE was recalled this week by the FDA for improperly packaged pills.

According to the Food and Drug Administration, the pills were packaged in a way that reversed the order of the tablets—meaning, the first four pills were actually placebos instead of active tablets. This could result in unwanted pregnancies and possible health issues for mother and baby.

Lupin Pharmaceuticals is specifically recalling lot L600518, Exp 05/18 of Mibelas 24 Fe birth control pills. They're packaged in blister packs containing 28 tablets: 24 white to off-white tablets of active ingredients debossed with “LU” on one side and “N81” on the other; and 4 tablets of inert ingredients debossed with “LU” on one side and “M22” on the other side. This product was distributed Nationwide in the U.S.A. to wholesalers, clinics and retail pharmacies.

Consumers who have the affected product should notify their physician and return the product to the pharmacy or place of purchase and contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.

Consumers with questions regarding this recall can contact Lupin by phone 1-800-399-2561.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: